Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m). Frontiers in psychiatry Beversdorf, D. Q., Anagnostou, E., Hardan, A., Wang, P., Erickson, C. A., Frazier, T. W., Veenstra-VanderWeele, J. 2022; 13: 1079006

View details for DOI 10.3389/fpsyt.2022.1079006

View details for PubMedID 36741580